Selected publications
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature Genetics.
2017
Academic Article
GET IT
Times cited: 63 -
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
2016
Review
GET IT
Times cited: 5 -
Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
PLoS ONE.
2015
Academic Article
GET IT
Times cited: 11 -
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
JAMA - Journal of the American Medical Association.
2015
Academic Article
GET IT
Times cited: 172 -
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
Human Molecular Genetics.
2015
Academic Article
GET IT
Times cited: 19 -
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nature Genetics.
2015
Review
GET IT
Times cited: 129 -
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
PLoS Genetics.
2014
Academic Article
GET IT
Times cited: 22 -
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 167 -
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA).
Cancer Epidemiology Biomarkers and Prevention.
2012
Academic Article
GET IT
Times cited: 253